In addition, whether the different types of maternal antibodies responsible for fetal anemia managed with IUT may influence treatment and outcomes is unclear, furthermore, whether anti-D alloimmunizations combined with other Rh associated antibody may have more adverse outcomes is also unknown. This evidence concerns the gene RHD and anemia.